Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity.

Nat Med · 2010 · PMC3786785 · PMID 20228816

Europe PMC DOI

hedged sentence

0.1590

closest p · 3.2× alpha

0.1590

boldest claim

The sentences

did not reach statistical significanceP =0.159not close (p > 0.1)

3c ), but did not reach statistical significance in bortezomib-treated patients ( P =0.159, log-rank test, Fig. 3d ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.